Related Experiment Video
Updated: Dec 4, 2025
12:28
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.6K
Targeting necroptosis in anticancer therapy: mechanisms and modulators
Ying Wu1, Guoqiang Dong1, Chunquan Sheng1,2
1School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Acta Pharmaceutica Sinica. B
|October 22, 2020
Summary
Necroptosis, a programmed cell death pathway, is crucial in cancer progression and immunity. Targeting necroptosis with small molecules offers a promising cancer therapy strategy by overcoming apoptosis resistance and enhancing antitumor responses.
Area of Science:
- Molecular Biology
- Cell Death Mechanisms
- Cancer Therapeutics
Background:
- Necroptosis, a genetically programmed form of necrotic cell death, plays a significant role in various human diseases.
- This cell-killing mechanism is implicated in cancer progression, metastasis, and the body's immune surveillance against tumors.
Purpose of the Study:
- To review recent advancements in understanding necroptosis mechanisms and detection methods.
- To highlight the critical role of necroptosis in cancer therapy and explore the medicinal chemistry of necroptosis modulators.
Main Methods:
- Literature review summarizing current research on necroptosis.
- Focus on the interplay between necroptosis and cancer treatment strategies.
- Analysis of small molecule modulators targeting the necroptosis pathway.
Main Results:
- Targeting necroptosis is an emerging therapeutic approach for cancer.
- This strategy can bypass resistance to apoptosis (programmed cell death) and preserve antitumor immunity.
- Understanding necroptosis mechanisms is key to developing novel cancer treatments.
Conclusions:
- Necroptosis modulators represent a promising avenue for cancer therapy.
- Further research into necroptosis mechanisms and medicinal chemistry is essential for clinical translation.
- Targeting necroptosis offers a way to combat cancer by leveraging cell death pathways and immune responses.
Related Concept Videos
02:57Targeted Cancer Therapies
8.3K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.3K
01:16Necrosis
5.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.8K
01:30Overview of Cell Death
8.7K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.7K
01:17The Extrinsic Apoptotic Pathway
7.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K
01:31The Intrinsic Apoptotic Pathway
7.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.7K